Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2007-02-20
2007-02-20
Azpuru, Carlos A. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
Reexamination Certificate
active
10703187
ABSTRACT:
The present invention relates to protein stabilized liposomes. Specifically, the present invention discloses compositions and methods for protein stabilized liposomes, the creation of protein stabilized liposomes, and the administration of protein stabilized liposomes.
REFERENCES:
patent: 4182330 (1980-01-01), Michaels
patent: 4485054 (1984-11-01), Mezei et al.
patent: 4515736 (1985-05-01), Deamer
patent: 4687661 (1987-08-01), Kikuchi et al.
patent: 4731210 (1988-03-01), Weder et al.
patent: 4826689 (1989-05-01), Violanto
patent: 4873035 (1989-10-01), Wong
patent: 5178875 (1993-01-01), Lenk et al.
patent: 5185154 (1993-02-01), Lasic et al.
patent: 5230899 (1993-07-01), Park et al.
patent: 5260065 (1993-11-01), Mathur et al.
patent: 5277914 (1994-01-01), Szoka, Jr.
patent: 5422120 (1995-06-01), Kim
patent: 5549910 (1996-08-01), Szoka, Jr.
patent: 5567433 (1996-10-01), Collins
patent: 5589189 (1996-12-01), Moynihan
patent: 5702722 (1997-12-01), Tournier et al.
patent: 5723147 (1998-03-01), Kim et al.
patent: 5753262 (1998-05-01), Wyse et al.
patent: 5766627 (1998-06-01), Sankaram et al.
patent: 5916596 (1999-06-01), Desai et al.
patent: 5993850 (1999-11-01), Sankaram et al.
patent: 5993851 (1999-11-01), Foldvari
patent: 6007838 (1999-12-01), Alving et al.
patent: 6071534 (2000-06-01), Kim et al.
patent: 6106858 (2000-08-01), Ye et al.
patent: 6132766 (2000-10-01), Sankaram et al.
patent: 6221401 (2001-04-01), Zasadzinski et al.
patent: 6277413 (2001-08-01), Sankaram
patent: 6306433 (2001-10-01), Andersson et al.
patent: 6355267 (2002-03-01), Collins
patent: 6447800 (2002-09-01), Hope
patent: 6497895 (2002-12-01), Uhrich
patent: 2002/0001613 (2002-01-01), Niemiec et al.
patent: 2002/0028219 (2002-03-01), Smyth-Templeton et al.
patent: 2002/0039596 (2002-04-01), Hartounian et al.
patent: 2002/0061331 (2002-05-01), Zasadzinski et al.
patent: 2002/0119188 (2002-08-01), Niemiec et al.
patent: 2002/0122819 (2002-09-01), Smyth-Templeton et al.
patent: 2002/0127272 (2002-09-01), Huang et al.
patent: 2002/0160039 (2002-10-01), Boni et al.
patent: 2003/0044454 (2003-03-01), Fukui et al.
patent: WO 90/03795 (1990-04-01), None
Papahadjopoulos et al., “Sterically Stabilized Liposomes: Improvements in Pharmacokinetic and Antitumor Therapeutic efficacy,” PNAS, vol. 88, pp. 11460-11464.
Papahadjopoulos et al. “Sterically Stabilized Liposomes: Improvements in Pharmacokinetic and Antitumor Therapeutic efficacy,” PNAS, vol. 88, pp. 11460-11464.
Papahodjopoulos et al., “Sterically Stabilized Liposomes: Improvements in Pharmacokinetic and Antitumor Therapeutic efficacy,” PNAS, vol. 88, pp. 11460-11464.
Beugin et al., “New sterically stabilized vesicles based on nonionic surfactant cholesterol and poly(ethylene glycol) cholesterol conjugates,”Biophysical J., 74: 3198-3210, 1998.
Cabanes et al., “Enhancement of antitumor activity of polyethylene glycol coated liposomal doxorubicin with soluble and liposomal interleukin 2,”Clinical Cancer Research, 5:687-693.
Drummond et al., “Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors,”Pharmacol. Rev., 51(4):691-744, 1999.
Gabizon and Papahadjopoulos, “Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors,”Proc. Nat. Acad. Sci. USA, 85: 6949-6953, 1988.
Lasic, Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times,Biochimica et Biophysica Acta, 1070: 187-192, 1991.
Müller and Müller-Goymann, “Influence of temperature on the manufacturing of liposomes,”Arch. Pharm. Med. Chem., 334(Suppl. 2):79, 2001.
Papahadjopoulos et al.., “Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy,”Proc. Nat. Acad. Sci. USA, 88:11460-11464, 1991.
Woodle et al., “Versatility in lipid compositions showing prolonged circulation with stericallly stabilized liposomes,”Biochimica and Biophysica Acta, 1105: 193-200, 1992.
Working et al., “Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating pegylated liposomes,”J Pharmacol and Exper Ther, 289(2):1128-1133, 1999.
Working et al., “Comparative target organ toxicity of free and liposome-encapsulated doxorubicin in rats,”Toxicologist, 14:217, 1994.
Working et al., “Pharmacokinetics, biodistribution, and therapeutic efficacy of doxorubicin encapsulated in stealth liposomes (Doxil),”Journal of Liposome Research, 4(1):667-687, 1994.
Azaya Therapeutics, Inc.
Azpuru Carlos A.
Fulbright & Jaworski LLP
LandOfFree
Protein-stabilized liposomal formulations of pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein-stabilized liposomal formulations of pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein-stabilized liposomal formulations of pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3859291